| Literature DB >> 34308024 |
Deep S Bhattacharya1, Aishwarya Bapat1, Denis Svechkarev1, Aaron M Mohs1,2,3.
Abstract
FluorescentEntities:
Year: 2021 PMID: 34308024 PMCID: PMC8296014 DOI: 10.1021/acsomega.1c01343
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1(A) Synthetic scheme for generation of fluorescent NCPDs from HA and precursor amino acids under mild acidic conditions. (B) Schematic for self-assembly of HA NCPDs. (C) DLS size distribution analysis of each NCPD. (D) Representative TEM images of the NCPDs. The scale bar represents 100 nm.
Figure 2Absorbance and fluorescence spectra of NCPDs in comparison with (A) precursor amino acids, for example, tryptophan, (B) HA-derived NCPD, and (C) after NaBH4 reduction.
Figure 3(A) CSLM images of CI66 cells incubated with HA-derived NCPDs for 4 h. Blue: NCPDs, green: endosomal marker, and pink: nuclear stain. (B) 3D CSLM images for CI66 spheroids incubated with a library of HA-derived NCPDs (C) Penetration of NCPDs in CI66-derived tumor spheroids, and accumulation of NCPDs in CI66 cells from spheroids indicated as mean fluorescence intensity after flow cytometry analysis. The results are shown as mean ± SD.
Figure 4(A) Schematic representation of DOX loading onto HA-derived NCPDs. (B) Fluorescence spectra of HA–tryptophan DOX-loaded NCPDs representing quenching of the parent blue signal and appearance of DOX fluorescence (520–620 nm).
Figure 5DOX release curve from HA-NCPDs and free DOX under different pH conditions, (A) 4.5 and (B) 7.4. Release profiles of tryptophan, tryptophan benzyl ester, and proline benzyl ester are shown. The cumulative release profile was obtained by taking samples from the release medium of the DOX-loaded NCPDs samples at specific time intervals.
Figure 6IC50 assessment on (A) CI66 and (B) CI66-DOX-resistant cells at three different time points (n = 6). (C) CI66 and (D) CI66-DOX-resistant cells were treated as indicated and stained with AnnexinV-FITC and Propidium Iodide (PI) using the FITC Annexin V Apoptosis Detection Kit I (BD Biosciences) and quantified with FACS. Representative scatter plots from each treatment are shown. The percent of late apoptotic/necrotic (Annexin V+/PI+) cells is quantified in each plot.
Figure 7(i) CI66 and (ii) CI66-DOX res: (A) CSLM images acquired on cells incubated with DOX-loaded HA-NCPDs for 4 h. Green, endosomal marker Rab5 protein and cyan-pink, nuclear stain. Combined images were analyzed to visualize uptake of DOX-loaded HA-NCPDs. Yellow arrows indicate localization of DOX through the red channel. (B) Representative CSLM images of tumor spheroids treated with different DOX-loaded HA-NCPDs for 12 h. Red: DOX-loaded HA-NCPDs. (C) Accumulation of DOX-loaded NCPDs in cells from trypsin-treated spheroids indicated as mean fluorescence intensity after FACS analysis (n = 3). The results are shown as mean ± SD.